-
-
Humanized model of the immune system
-
iHuPBMC-T
-
iHuPBMC-NK
-
iHuPBMC-B
-
PBMC-LT
-
CD34+ HSC
-
Winn model
-
iHuPBMC-MHC/KO
-
iHuPBMC-OncVax
-
PBMC mixed inoculation model
more -
-
In vivo tumor experimental platform
-
CDX
-
iHuPDX
-
Non-GLP Toxicology
-
PK/PD
-
Brain in situ model
-
Other in situ models
-
Hematologic tumor model system inoculation
-
Creation of high interstitial tumor models
more -
-
In vitro killing experiment platform
-
Immune co-culture killing model
-
CDC
-
In vitro killing experiment platform
-
IC50
-
PDC High-Throughput In Vitro Pharmacodynamics
-
3D organoids
-
ADCC
-
T cell-mediated killing experiment
more -
-
Mouse-derived immune system model
more -
Tumor vaccine
more -
Cell therapy
more -
In vitro testing platform
more -
Non-GLP Toxicology Platform
more -
Non-tumor model and drug efficacy evaluation platform
-
Systematic Vaccination Model
-
Non-tumor model and drug efficacy evaluation platform
-
Skin injury model
-
Stroke model
-
Liver fibrosis model
-
Diabetes model
-
Gouty Arthritis (GA) Model
-
Pulmonary fibrosis model
-
Systemic lupus erythematosus (SLE) model
-
Inflammatory Bowel Disease (IBD) model
-
Rheumatoid Arthritis (RA) Model
more -
-
-
-
PDX model
-
PDX model
-
Head and neck cancer
-
Eye cancer
-
Lung cancer
-
Human breast cancer
-
Esophageal cancer in humans
-
Human gastric cancer
-
Colorectal cancer
-
Human liver cancer
-
Bile duct cancer
-
Gallbladder cancer
-
Human pancreatic cancer
-
Human kidney cancer
-
Human Bladder Cancer
-
Ureteral cancer
-
Prostate cancer
-
Uterine cancer
-
Cervical cancer in women
-
Human Ovarian Cancer
-
Human skin cancer
-
sarcoma
-
Human Nervous System Cancer
-
Embryonal carcinoma
-
Human Lymphoma
-
Human leukemia
-
Multiple Myeloma
-
Adrenal gland
-
Mesothelioma
-
Other people
more -
-
CDX model
-
CDX model
-
Head and neck cancer
-
Eye cancer
-
Lung cancer
-
Human breast cancer
-
Esophageal cancer in humans
-
Human gastric cancer
-
Colorectal cancer
-
Human liver cancer
-
Bile duct cancer
-
Gallbladder cancer
-
Human pancreatic cancer
-
Human kidney cancer
-
Human Bladder Cancer
-
Ureteral cancer
-
Prostate cancer
-
Uterine cancer
-
Cervical cancer in women
-
Human Ovarian Cancer
-
Human skin cancer
-
sarcoma
-
Human Nervous System Cancer
-
Embryonal carcinoma
-
Human Lymphoma
-
Human leukemia
-
Multiple Myeloma
-
Adrenal gland
-
Mesothelioma
-
Other people
more -
-
Homogeneous Model
-
Homogeneous Model
-
Head and neck cancer
-
Eye cancer
-
Lung cancer
-
Breast cancer
-
Stomach cancer
-
Liver cancer
-
Bile duct cancer
-
Gallbladder cancer
-
Pancreatic cancer
-
Kidney cancer
-
Bladder cancer
-
Ureteral cancer
-
Prostate cancer
-
Uterine cancer
-
Cervical cancer
-
Ovarian cancer
-
Esophageal cancer
-
Skin cancer
-
sarcoma
-
Nervous System Cancer
-
Embryonal carcinoma
-
Lymphoma
-
Leukemia
-
Multiple Myeloma
-
Adrenal gland
-
Mesothelioma
-
Other
-
Colorectal cancer
more -
-
News Center
——
InnoModels Biotechnology IC50 Cell Activity Assay Platform
Author:
InnoModels
Release time:
2024-05-07
As an important tool for biomedical research, the IC50 cell activity assay platform of InnoModels Biotechnology (Beijing) Co., Ltd. provides powerful technical support for drug discovery, disease mechanism research and other fields. With its rich experience in drug discovery and development, advanced experimental technology and extensive cooperative network, the platform provides researchers with efficient, accurate and reliable cell activity assay services.
1、Rich experience in drug discovery and development
InnoModels Biotechnology has an experienced drug discovery team with profound knowledge in drug screening, optimization and mechanism of action research. This enables the company to have high accuracy and reliability in the determination of IC50 values. In addition, the laboratory staff has more than 15 years of experience and specializes in IC50 determination and cell culture technology, which provides professional and stable technical support for cell activity detection.
2、Advanced experimental technology
InnoModels Biotechnology adopts advanced experimental techniques, such as high-content imaging system and bioinformatics analysis, to precisely analyze the interaction between drugs and targets. These technologies help to improve the accuracy and sensitivity of IC50 value determination, providing researchers with more accurate and reliable experimental data.
3、Wide cooperation network
InnoModels Biotechnology has established an extensive cooperation network with a number of research institutions and enterprises at home and abroad, which promotes the progress of biomedical research by sharing resources and technologies. This mode of cooperation not only helps to enhance the company's R&D strength, but also provides researchers with more opportunities for cooperation and promotes the transformation and application of research results.

4、Strict data quality control
InnoModels Biotechnology attaches great importance to the quality of data and the safety of experiments. All cells are tested for STR (Short Tandem Repeat Sequence) before use to ensure the accuracy of cell identity. In addition, the company regularly tests for mycoplasma and chlamydia in the cell culture solution to ensure the reliability and safety of the experiments. These measures provide researchers with high-quality and credible experimental data, and provide strong support for drug development and disease mechanism research.
5、Diverse cell line selection
InnoModels Biotechnology has more than 400 human-derived tumor cell lines, covering a wide range of cancer types and subtypes. This means that researchers can easily select cell lines on the platform that suit their research needs, whether for anti-cancer drug screening or mechanism studies. This diverse selection of cell lines provides researchers with a broader research space and helps promote innovation in the biomedical field.
6、Stable and Repeatable Data
InnoModels' platform is known for its stable and reproducible data. The company strictly follows a standardized experimental process to ensure that the results of each experiment are credible. This stability and reproducibility provides researchers with reliable data support, allowing them to analyze and compare data with confidence and support their research.
In summary, the IC50 cell activity assay platform of InnoModels Biotechnology has become a powerful assistant for biomedical research with its rich experience in drug discovery and development, advanced experimental technology, extensive collaborative network, stringent data quality control, diverse selection of cell lines, and stable and reproducible data. The platform provides powerful technical support for drug discovery, disease mechanism research and other fields, and makes important contributions to the advancement of biomedical field.
InnoModels Biotechnology (Beijing) Co., Ltd.
-
TEL: +86 15711355061
-
E-mail: xuyl@imodels.tech
-
Address: Building 14, No. 79 West Shuangying Road, Changping District, Beijing
COOKIES
Our website uses cookies and similar technologies to personalize the advertising shown to you and to help you get the best experience on our website. For more information, see our Privacy & Cookie Policy
COOKIES
Our website uses cookies and similar technologies to personalize the advertising shown to you and to help you get the best experience on our website. For more information, see our Privacy & Cookie Policy
These cookies are necessary for basic functions such as payment. Standard cookies cannot be turned off and do not store any of your information.
These cookies collect information, such as how many people are using our site or which pages are popular, to help us improve the customer experience. Turning these cookies off will mean we can't collect information to improve your experience.
These cookies enable the website to provide enhanced functionality and personalization. They may be set by us or by third-party providers whose services we have added to our pages. If you do not allow these cookies, some or all of these services may not function properly.
These cookies help us understand what you are interested in so that we can show you relevant advertising on other websites. Turning these cookies off will mean we are unable to show you any personalized advertising.
InnoModels Biotechnology (Beijing) Co., Ltd